SCHEMBL14723477

SCHEMBL14723477

Cc1cc(C2CN(c3ncc(C(=O)O)cn3)CC2NC(=O)OC(C)(C)C)c(F)cc1F

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 1/20 0.36
MAP3K5 Q99683 2/20 0.33
DPP4 P27487 4/20 0.33
KDM1A O60341 2/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
NR1H2 P55055 1/20 0.33
RET P07949 2/20 0.32
EIF2AK4 Q9P2K8 1/20 0.32
CKS1B P61024 1/20 0.32
SKP1 P63208 1/20 0.32
SKP2 Q13309 1/20 0.32
MAOB P27338 1/20 0.32
F2R P25116 1/20 0.32
POLB P06746 1/20 0.32
PDE4B Q07343 2/20 0.31
GPR119 Q8TDV5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6128110 1.00 RBP4 (0.36) RBP4MAP3K5DPP4KDM1ADPP8
SCHEMBL14730335 0.94 DPP4 (0.38) RBP4DPP4KDM1ADPP8DPP9
SCHEMBL14723098 0.92 NR1H2 (0.38) MAP3K5DPP4KDM1ADPP8DPP9
SCHEMBL14722979 0.87 NTRK1 (0.41) RBP4DPP4KDM1ANR1H2RET
SCHEMBL6128115 0.87 NTRK1 (0.41) RBP4DPP4KDM1ANR1H2RET
SCHEMBL14723221 0.85 NR1H2 (0.40) DPP4KDM1ADPP8DPP9DPP7
SCHEMBL14730330 0.85 NR1H2 (0.40) DPP4KDM1ADPP8DPP9DPP7
SCHEMBL14722985 0.85 RBP4 (0.45) RBP4KDM1AEIF2AK4CKS1BSKP1
SCHEMBL14723584 0.80 NR1H2 (0.41) MAP3K5KDM1ANR1H2RETEIF2AK4
SCHEMBL14730264 0.79 HPGDS (0.38) DPP4KDM1ADPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed